Literature DB >> 26100750

Interactions of the histamine and hypocretin systems in CNS disorders.

Ling Shan1, Yves Dauvilliers2, Jerome M Siegel1.   

Abstract

Histamine and hypocretin neurons are localized to the hypothalamus, a brain area critical to autonomic function and sleep. Narcolepsy type 1, also known as narcolepsy with cataplexy, is a neurological disorder characterized by excessive daytime sleepiness, impaired night-time sleep, cataplexy, sleep paralysis and short latency to rapid eye movement (REM) sleep after sleep onset. In narcolepsy, 90% of hypocretin neurons are lost; in addition, two groups reported in 2014 that the number of histamine neurons is increased by 64% or more in human patients with narcolepsy, suggesting involvement of histamine in the aetiology of this disorder. Here, we review the role of the histamine and hypocretin systems in sleep-wake modulation. Furthermore, we summarize the neuropathological changes to these two systems in narcolepsy and discuss the possibility that narcolepsy-associated histamine abnormalities could mediate or result from the same processes that cause the hypocretin cell loss. We also review the changes in the hypocretin and histamine systems, and the associated sleep disruptions, in Parkinson disease, Alzheimer disease, Huntington disease and Tourette syndrome. Finally, we discuss novel therapeutic approaches for manipulation of the histamine system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26100750      PMCID: PMC8744538          DOI: 10.1038/nrneurol.2015.99

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  160 in total

Review 1.  Histamine in the nervous system.

Authors:  Helmut L Haas; Olga A Sergeeva; Oliver Selbach
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

2.  Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.

Authors:  Alvaro Alonso; Susan S Jick; Miguel A Hernán
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

3.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

Authors:  B Kremer; P Goldberg; S E Andrew; J Theilmann; H Telenius; J Zeisler; F Squitieri; B Lin; A Bassett; E Almqvist
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

4.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

5.  Impaired ventilation and metabolism response to hypoxia in histamine H1 receptor-knockout mice.

Authors:  Takashi Ishiguro; Michiko Iwase; Mitsuko Kanamaru; Masahiko Izumizaki; Yasuyoshi Ohshima; Ikuo Homma
Journal:  Respir Physiol Neurobiol       Date:  2006-03-15       Impact factor: 1.931

6.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Authors:  Yves Dauvilliers; Claudio Bassetti; Gert Jan Lammers; Isabelle Arnulf; Geert Mayer; Andrea Rodenbeck; Philippe Lehert; Claire-Li Ding; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

7.  Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Authors:  Thomas Roth; Roberta Rogowski; Steven Hull; Howard Schwartz; Gail Koshorek; Bruce Corser; David Seiden; Alan Lankford
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

8.  Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

Authors:  J M Siegel; R Nienhuis; H M Fahringer; R Paul; P Shiromani; W C Dement; E Mignot; C Chiu
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

Review 9.  Cataplexy--clinical aspects, pathophysiology and management strategy.

Authors:  Yves Dauvilliers; Jerry M Siegel; Regis Lopez; Zoltan A Torontali; John H Peever
Journal:  Nat Rev Neurol       Date:  2014-06-03       Impact factor: 42.937

10.  Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-09-26       Impact factor: 13.501

View more
  28 in total

1.  Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.

Authors:  W Joseph Herring; Kathleen M Connor; Ellen Snyder; Duane B Snavely; Ying Zhang; Jill Hutzelmann; Deborah Matzura-Wolfe; Ruth M Benca; Andrew D Krystal; James K Walsh; Christopher Lines; Thomas Roth; David Michelson
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

Review 2.  Development of the hypothalamus: conservation, modification and innovation.

Authors:  Yuanyuan Xie; Richard I Dorsky
Journal:  Development       Date:  2017-05-01       Impact factor: 6.868

Review 3.  Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour.

Authors:  Patricia Bonnavion; Laura E Mickelsen; Akie Fujita; Luis de Lecea; Alexander C Jackson
Journal:  J Physiol       Date:  2016-07-19       Impact factor: 5.182

4.  Hypothalamic Tuberomammillary Nucleus Neurons: Electrophysiological Diversity and Essential Role in Arousal Stability.

Authors:  Akie Fujita; Patricia Bonnavion; Miryam H Wilson; Laura E Mickelsen; Julien Bloit; Luis de Lecea; Alexander C Jackson
Journal:  J Neurosci       Date:  2017-09-05       Impact factor: 6.167

5.  Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.

Authors:  Qian-Xing Zhuang; Han-Ting Xu; Xu-Juan Lu; Bin Li; Wing-Ho Yung; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

6.  Memory Consolidation Is Similar in Waking and Sleep.

Authors:  Jerome M Siegel
Journal:  Curr Sleep Med Rep       Date:  2021-01-14

7.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

8.  Impaired histaminergic neurotransmission in children with narcolepsy type 1.

Authors:  Patricia Franco; Yves Dauvilliers; Clara Odilia Inocente; Aurore Guyon; Carine Villanueva; Veronique Raverot; Sabine Plancoulaine; Jian-Sheng Lin
Journal:  CNS Neurosci Ther       Date:  2018-09-17       Impact factor: 5.243

9.  Regularizing firing patterns of rat subthalamic neurons ameliorates parkinsonian motor deficits.

Authors:  Qian-Xing Zhuang; Guang-Ying Li; Bin Li; Chang-Zheng Zhang; Xiao-Yang Zhang; Kang Xi; Hong-Zhao Li; Jian-Jun Wang; Jing-Ning Zhu
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

10.  Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics.

Authors:  William T Schneider; Szilvia Vas; Alister U Nicol; A Jennifer Morton
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.